| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f677b51d501b7faa84a3a5cba20c00a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1077 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
| filingDate |
2019-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fc6ee749f4d2ffb8742ca5444f09a6f |
| publicationDate |
2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112118871-A |
| titleOfInvention |
Fractionated dosing of phospholipid ether analogs for the treatment of cancer |
| abstract |
Disclosed herein is a fractionated dosing regimen of131I -labeled 18-(p-iodo-phenyl)octadecylphosphocholine for the treatment of cancer. |
| priorityDate |
2018-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |